Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Presentation of second quarter interim report

Stavanger 26 August 2015: As previously announced, Norwegian Energy Company ASA and Noreco Norway AS (Noreco) will publish interim reports for the second quarter on Thursday 27 August. The reports will be published on www.newsweb.no and www.noreco.com. Management will be available in an earnings call on Thursday 27 August at 09:00 CET. The presentation material for the call will be published in parallel with the interim reports. After a brief presentation, questions will be answered. Please forward any questions you may have to investorrelations@noreco.com, preferably prior to the call.

Acetium family grows during September

Biohit Oyj Press Release August 26, 2015 at 9:30 a.m. local time (EEST) Acetium product family grows with a new lozenge flavor. A consumer survey chose salty liquorice as the Finns’ favorite flavor. In the future, the package color will indicate the flavor. The new flavor will be in Finnish pharmacies during September. Acetium lozenge effectively binds carcinogenic acetaldehyde (increases the risk of cancer) from saliva and forms a harmless compound that can be excreted from the body. The lozenge removes over 90 percent of the acetaldehyde dissolved into saliva during smoking and

Alfa Laval wins SEK 90 million marine offshore order

Alfa Laval – a world leader in heat transfer, centrifugal separation and fluid handling – has won an order to supply its Alfa Laval Aalborg boiler modules for an FPSO vessel to be built in China. The order, booked in the Marine & Offshore Systems segment, has a value of approximately SEK 90 million and delivery is scheduled for 2016.The boiler modules will be included in the power generation system of the FPSO vessel where they predominately will generate steam for the steam turbines but also provide cargo tank heating. Once built, the vessel will be anchored outside the Nigerian coast. “

NICOCCINO APPROVED AS A CONSUMER PRODUCT IN THE CZECH REPUBLIC

Authorities in the Czech Republic have approved NicoccinoTM to be marketed and sold as a consumer product. The approval clarifies the categorization of Nicoccino within the European Union and paves the way for further sales in other EU countries. The approval decreases the company risk in relation to regulation of the product.The approval from the Czech authorities means that NicoccinoTM is not classified as food, tobacco or a pharmaceutical product. As a consequence, NicoccinoTM can be marketed and sold as a consumer product. Sales through distributors will be initiated at the beginning of

Recipharm Signs Agreement with RedHill Biopharma for Manufacturing of RHB-105 for treatment of H. pylori infection

Recipharm AB, Stockholm, today announces that it has signed an agreement with Israeli biopharmaceutical company RedHill Biopharma Ltd (TASE/NASDAQ: RDHL) (“RedHill”) for the manufacturing of RedHill’s leading, late-stage patented drug candidate, RHB-105. RHB-105 is being developed for the treatment of Helicobacter pylori (H. pylori) bacterial infection, a global market estimated at about $4.8 billion.  Recipharm will be responsible for the supply of the remaining clinical trial material and ongoing future commercial supply.RHB-105 is a new and proprietary fixed-dose oral combination therapy

INTERIM REPORT JANUARY–JUNE 2015

Divestment of Compressor Technology and Waste Heat Recovery business · Share purchase agreement signed concerning the sale of business activities within Compressor Technology and Waste Heat Recovery for SEK 400 million, expected closing by 30 September 2015 · Operating loss (EBITDA) before depreciation for Q2 was SEK 3.4 million ( –6.4 m) · Earnings for remaining business affected by costs attributable to divestment and over-dimensioned administration · Strategic review of remaining business has started Q2, April-June 2015, remaining business · Net sales amounted to

Hexagon Composites ASA: Hexagon Raufoss restructures the operating model

Hexagon Composites' wholly-owned subsidiary Hexagon Raufoss, restructures its operating model to achieve profitable operations.As a result of prolonged weak profitability, the decision has been taken to implement a restructuring and downsizing process in Hexagon Raufoss. The company has terminated all its employee contracts and has implemented a modified operating model where operational services will be performed by its sister company Hexagon Ragasco. The restructuring includes workforce reductions through natural retirements, internal transfers and lay-offs. Eight employees have found

Annual General Meeting of Lagercrantz Group AB 25 August 2015

Resolutions including the following were passed by the Annual General Meeting and the ensuing statutory Board of Directors Meeting held 25 August 2015: Dividend A dividend of SEK 4.50 per share was declared in accordance with the proposal of the Board of Directors. Friday, 27 August 2015 is record day for receiving dividend that is expected to be remitted by Euroclear Sweden AB Tuesday, 1 September 2015.  Discharge from liability for the directors and the President The Annual General Meeting granted discharge from liability to the Board of Directors and the President for their

Interim report January - June 2015

● Revenue increased 10 per cent to SEK 1,527 M (1,387). Adjusted for currency effects and calculated on the comparable number of workdays, revenue rose 10 per cent.● EBITA rose 7 per cent to SEK 224 M (210) and the EBITA margin amounted to 15 per cent (15).● EBIT increased 8 per cent to SEK 197 M (182) and the EBIT margin totalled 13 per cent (13).● The gross margin amounted to 54.7 per cent (55.2).● Earnings per share, before and after dilution, amounted to SEK 3.74 (3.74).● Cash flow from operating activities amounted to SEK 137 M (192), of which discontinued operations

University Hospital La Timone world’s first to treat patients with Leksell Gamma Knife Icon, Elekta’s latest generation cranial radiosurgery system

New technology in Icon revolutionizes frameless radiosurgery, adding continuous dose control and motion management for greater patient safety, accuracy and efficiencyMARSEILLES, France, August 26, 2015 – On August 10, doctors at University Hospital La Timone (Marseilles, France) used their new Leksell Gamma Knife® Icon™ system to treat a metastasis in the brain of a 71-year-old female patient. This single-session treatment was the first time La Timone physicians had harnessed the system’s advanced motion management and imaging capabilities to enable therapy using mask-based head fixation

Moelven earned NOK 48 million

This year, Moelven’s second quarter profits from its operations amounted to NOK 48 million. That is 35 million less than in the corresponding period last year. But before impairments and cost corrections, underlying operations showed an improved performance.Acting CEO Morten Kristiansen of Moelven Industrier ASA believes that the underlying results show that the Group is in good shape.“Basically we can see a better second quarter this year than in the same period last year, and we see the results of efficiency measures in several of our businesses. Further efficiency measures were

BAKKAFROST - Share Saving Plan Transaction

As a part of the share saving plan for employees in 2015, the following primary insiders have purchased Bakkafrost shares: Regin Jacobsen, CEO, purchased 80 shares. After the transaction he holds 4,492,863 shares. Gunnar Nielsen, CFO, purchased 47 shares. After the transaction he holds 226 shares. Odd Eliasen, Managing Director, purchased 60 shares. After the transaction he holds 171,216 shares. Annika Frederiksberg, Board Member, purchased 26 shares. After the transaction she holds directly and indirectly 14,757 shares. The shares were purchased from P/F Bakkafrost on 25

NORDIC NANOVECTOR: RESULTS FOR THE SECOND QUARTER AND HALF YEAR 2015

Oslo, Norway, 26 August 2015: Nordic Nanovector ASA (OSE: NANO), a company focusing on the development and commercialisation of novel targeted therapeutics in haematology and oncology, announces its results for the second quarter and half year 2015. A presentation of the results by Nordic Nanovector’s senior management team will take place today at 8:30am CEST in Oslo, details are below. Luigi Costa, CEO of Nordic Nanovector, said: “Following the great start to 2015, which saw the Company complete an upsized and oversubscribed IPO, we continue to execute the clinical development

Multiconsult second quarter 2015 results: Improved billing ratio and strong earnings

Oslo, 26 August 2015 – Underlying EBITDA for the quarter, adjusted for one-off IPO expenses, rose 34 per cent to NOK 71.1 million. Focused efforts on improving the billing ratio proved successful, which combined with a positive calendar effect and high project activity led to increased profitability. Group net operating revenues increased by 14 per cent to NOK 557.5 million, driven by high project activity within Transportation & Infrastructure, Energy, Buildings & Properties and Industry.“I am very pleased to see that our intensified and focused efforts to improve the billing ratio have

Seven physician-researchers awarded a total of $675,000 in grants for radiation oncology research

Fairfax, Va., August 25, 2015—The American Society for Radiation Oncology (ASTRO) has selected seven leading physician-researchers to receive a total of $675,000 in awards and grants to advance radiation oncology research. Together, the seven funding grants, including ASTRO Junior Faculty Career Research Training Award, the ASTRO Residents/Fellows in Radiation Oncology Research Seed Award and the ASTRO/Radiation Oncology Institute (ROI) Comparative Effectiveness Research Award, will support studies in radiation and cancer biology, radiation physics, translational research, outcomes/health

Nanolab Technologies LEAPS Forward with High-Performance Analysis Services to the World

Nanolab Orders Advanced Local Electrode Atom Probe (LEAP) Microscope from CAMECA unit of AMETEK Materials Analysis DivisionMilpitas, CA – Nanolab Technologies Inc., a Silicon Valley-based analytical services lab, has purchased a new Local Electrode Atom Probe from CAMECA Instruments Inc. The high-performance atom probe from CAMECA, a unit of the AMETEK Materials Analysis Division, is used to provide advanced materials analysis, including precise atom-by-atom identification, 3-D spatial positioning, and accurate atomic-scale reconstruction of a material’s microstructure.  Since their

NCCN Publishes New Patient Education Resources for Kidney Cancer

NCCN has published the NCCN Guidelines for Patients® and NCCN Quick Guide™ for Kidney Cancer, the newest addition to the library of NCCN Guidelines for Patients.FORT WASHINGTON, PA —Kidney Cancer is among the 10 most diagnosed cancers in both men and women in the United States, and it is estimated that more than 60,000 new cases of kidney cancer will be diagnosed in 2015.[1] The National Comprehensive Cancer Network® (NCCN ®) has published the NCCN Guidelines for Patients® and NCCN Quick Guide™ for Kidney Cance 

AVALANCHE STUDIOS IN THE WASTELAND

With only a week to go until the release of Mad Max, we wanted to share one of our favorite experiences from this journey.Most game developers never get to touch anything they create. Their work is forever locked behind glass screens. So when the centerpiece of the upcoming Mad Max game – a unique car called the Magnum Opus – would be re-created in real life, it was an overwhelming experience for the team at Avalanche Studios. In this short documentary, we get to follow Lead Artist Daniel Persson, the original designer of the Magnum Opus, and Odd Ahlgren, Director of Narrative Content,

NEW SCHMITZ CARGOBULL MULTI-TEMP FRIDGE TO GET UK PREMIERE AT TCS&D SHOW

25 August 2015Schmitz Cargobull will give the multi-temp version of its flagship S.KO COOL EXECUTIVE its UK premiere at the Temperature Controlled Storage & Distribution (TCS&D) Show next month, the first chance for British customers to get hands-on experience of the very latest in refrigerated trailer technology. The S.KO COOL EXECUTIVE is Schmitz Cargobull’s top-of-the-range temperature controlled trailer, exclusively featuring its own-brand temperature controlled refrigeration unit. The launch of the multi-temp system follows the 2014 domestic launch of the mono-temp model in the UK.

Orexo’s Upcoming Presentations at Events during Second Half 2015

Uppsala, Sweden – August 25, 2015 – Orexo AB (publ) informs today that the company will be presenting at the following events during the fall of 2015. August 28:            Pareto Securities’ 6th Annual Health Care Seminar, Stockholm September 3:        Redeye Open Investor Forum, Stockholm October 22:           Release of Orexo Q3 Interim Report followed by audio cast October 30:           ProHearings Investor Presentation, Stockholm November 18/19:  Jefferies Autumn 2015 Global Healthcare Conference, London December 15:       Guggenheim’s Boston One-on-One Healthcare Day,

Beautifully Quiet Ice:

Scotsman’s new hotel guest self-serve ice machine is user-friendly, hygienic and quietMaking sure guests have a ready supply of ice is increasingly important in today’s hotels. Usually the self-serve unit will be placed in lobbies, lounges or hotel bedroom corridors, and usually most of the ice will be taken at night. So apart from ensuring that the ice itself is top quality, hotel owners are looking for machines that are easy to use, as hygienic as possible and operate quietly – to minimise disruption for other guests. Now Hubbard Systems has launched a new Scotsman ice dispenser, the

There are no items matching the current filter
There are no more items matching the current filter
Back to top